Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infections
- 1 May 1988
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Surgery
- Vol. 155 (5) , 56-60
- https://doi.org/10.1016/s0002-9610(88)80214-9
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Moxalactam versus clindamycin plus tobramycin in the treatment of obstetric and gynecologic infectionsAmerican Journal of Obstetrics and Gynecology, 1985
- Imipenem/Cilastatin in the Treatment of Obstetric and Gynecologic Infections: A Review of Worldwide ExperienceClinical Infectious Diseases, 1985
- Failure of β-Lactam Antibiotics to Eradicate Chlamydia trachomatis in the Endometrium Despite Apparent Clinical Cure of Acute SalpingitisJAMA, 1983
- A double-blind, randomized comparison of moxalactam versus clindamycin-gentamicin in treatment of endomyometritis after cesarean section deliveryAmerican Journal of Obstetrics and Gynecology, 1983
- Comparative study of piperacillin versus cefoxitin in the treatment of obstetric and gynecologic infectionsAmerican Journal of Obstetrics and Gynecology, 1983
- In vitro activity of cefotetan, a new cephamycin derivative, compared with that of other beta-lactam compoundsAntimicrobial Agents and Chemotherapy, 1982
- Treatment of mixed aerobic-anaerobic infections of the female genital tractJournal of Antimicrobial Chemotherapy, 1981
- A comparison of clindamycin-gentamicin and penicillin-gentamicin in the treatment of post–cesarean section endomyometritisAmerican Journal of Obstetrics and Gynecology, 1979
- Polymicrobial Etiology of Acute Pelvic Inflammatory DiseaseNew England Journal of Medicine, 1975